evolcSign inStart free
Menu

Nuclearmedix

Develops radiopharmaceuticals for cancer diagnosis and treatment, with an initial focus on neuroendocrine tumour imaging

London, United KingdomFounded 2024nuclearmedix.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-10

About Nuclearmedix

NuclearMediX develops radiopharmaceuticals designed for reliable production and wider patient access. Its lead programme, FETO (NMX-001A), is an 18F PET tracer targeting SSTR2, initially for neuroendocrine tumours; the company also describes programmes using astatine-211 and terbium-161.

Its platform uses click chemistry and single-use cassettes for automated tracer synthesis and multi-site production. NuclearMediX grew from research at Imperial College London and is registered in London, United Kingdom, with a founding date of 2024.

Product: Radiopharmaceutical development, including the FETO SSTR2 PET tracer and cassette-based radiolabelling technology.

Jobs at Nuclearmedix

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Nuclera

    Automated protein screening instrument and antibody triage services for protein scientists and biopharma labs
    Cambridge, United KingdomBiotech & pharmaFounded 20132 open jobs

  • Nuclide Therapeutics

    Develops targeted radiopharmaceutical therapies for patients with treatment-resistant cancers
    London, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Octapharma

    Plasma-derived medicines for patients with rare diseases, coagulopathies and bleeding disorders
    Manchester, United KingdomBiotech & pharmaFounded 1989
    New on Evolc

  • Ogi Bio

    Automated modular bioreactors and culturing systems for scientists studying microbial growth and cultures
    Edinburgh, United KingdomBiotech & pharmaFounded 2020
    New on Evolc

  • OMass Therapeutics

    Drug discovery company developing small-molecule medicines for immunological and orphan diseases
    United KingdomBiotech & pharma1 open job
    New on Evolc

  • Oppilotech

    Computational biology modelling and drug discovery for pharmaceutical and biotech companies
    London, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.